Follow
Roshni Nambiar
Roshni Nambiar
NGM Biopharmaceuticals
Verified email at ngmbio.com
Title
Cited by
Cited by
Year
Targeting epigenetic modifiers of tumor plasticity and cancer stem cell behavior
VE Kumar, R Nambiar, C De Souza, A Nguyen, J Chien, KS Lam
Cells 11 (9), 1403, 2022
222022
Long non-coding RNA signatures as predictors of prognosis in thyroid cancer: a narrative review
H Zhao, C De Souza, VE Kumar, R Nambiar, D Hao, X Zhu, Y Luo, S Liu, ...
Annals of translational medicine 9 (4), 2021
102021
Exploring the therapeutic potential of Neem (Azadirachta Indica) for the treatment of prostate cancer: a literature review
N Batra, VE Kumar, R Nambiar, C De Souza, A Yuen, U Le, R Verma, ...
Annals of translational medicine 10 (13), 2022
82022
The P72R polymorphism in R248Q/W p53 mutants modifies the mutant effect on epithelial to mesenchymal transition phenotype and cell invasion via CXCL1 expression
C De Souza, JA Madden, D Minn, VE Kumar, DJ Montoya, R Nambiar, ...
International Journal of Molecular Sciences 21 (21), 8025, 2020
82020
The system can't perform the operation now. Try again later.
Articles 1–4